Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 223.61 | 226.77 |
| 52-Wk Range | - | - |
| Last Close | 226.43 |
| Mkt Cap (m) | 133,196.86 |
| Dividend yield | 2.69 |
| ISIN | US0311621009 |
| Volume | 2,334,329.00 |
| Exchange Venue | NAS |
Company Profile
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Key Information
| Price/Earning | 17.73 |
| Price/Book | 14.04 |
| Price/Sales | 5.68 |
| P/CF | 14.42 |
| Rev Growth (3 year avg) | 0.54 |
| EPS Growth (3 year avg) | 0.08 |
| Operating Margin % | 41.41 |
| Net Margin % | 33.57 |
| Return on Equity | 70.73 |
| Debt/Equity | 3.09 |
Documents
Prospectus
| en 06/05/2020 |
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 20,063.00 | 21,662.00 | 22,991.00 | 22,849.00 | 23,747.00 | 23,362.00 |
| Operating Income (m) | 6,191.00 | 8,470.00 | 9,794.00 | 9,973.00 | 10,263.00 | 9,674.00 |
| Net Income (m) | 5,158.00 | 6,939.00 | 7,722.00 | 1,979.00 | 8,394.00 | 7,842.00 |
| Basic EPS | 6.80 | 9.15 | 10.32 | 2.71 | 12.70 | 12.96 |
| Avg. Diluted Shares Outstanding (m) | 770.00 | 766.00 | 754.00 | 735.00 | 665.00 | 609.00 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 34,713.00 | 38,518.00 | 46,010.00 | 49,476.00 | 37,618.00 | 18,440.00 |
| Non Current Assets (m) | 34,296.00 | 33,058.00 | 31,616.00 | 30,478.00 | 28,798.00 | 41,267.00 |
| Total Assets (m) | 69,009.00 | 71,576.00 | 77,626.00 | 79,954.00 | 66,416.00 | 59,707.00 |
| Current Liabilities (m) | 7,008.00 | 8,667.00 | 11,204.00 | 9,020.00 | 13,488.00 | 12,835.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 25,778.00 | 28,083.00 | 29,875.00 | 25,241.00 | 12,500.00 | 9,673.00 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 8,555.00 | 9,077.00 | 10,354.00 | 11,177.00 | 11,296.00 | 9,150.00 |
| Capital Expenditure (m) | -1,003.00 | -649.00 | -837.00 | -664.00 | -738.00 | -618.00 |
Figures are quoted in USD unless stated otherwise
-
No change
$
226.43
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.